Opioid Epidemic

(Image: Getty/Kevron2001)

FDA aims to speed naloxone generics to market

By Ben Hargreaves

US FDA follows up the first generic approval of naloxone nasal spray by encouraging companies to apply with generic applications amid the North American opioid crisis.

(Image: Getty/Martin Barraud)

July roundup: Regulators experience a busy month

By Ben Hargreaves

July has seen a number of actions taken by regulators to manage the supply of medicine, including a crackdown on CBD manufacturers and repackers of opioid medication.